Back to Search Start Over

Sexuality after total vs. subtotal hysterectomy.

Authors :
Zobbe, Vibeke
Gimbel, Helga
Andersen, Birthe Margrethe
Filtenborg, Thomas
Jakobsen, Kristian
Sørensen, Helle Christina
Toftager-Larsen, Kim
Sidenius, Katrine
Møller, Nini
Madsen, Ellen Merete
Vejtorp, Mogens
Clausen, Helle
Rosgaard, Annie
Gluud, Christian
Ottesen, Bent S
Tabor, Ann
Source :
Acta Obstetricia et Gynecologica Scandinavica; Feb2004, Vol. 83 Issue 2, p191-196, 6p
Publication Year :
2004

Abstract

<bold>Background: </bold>The effect of hysterectomy on sexuality is not fully elucidated and until recently total and subtotal hysterectomies have only been compared in observational studies.<bold>Aims: </bold>To compare total abdominal hysterectomy (TAH) to subtotal abdominal hysterectomy (SAH) regarding effects on sexuality.<bold>Methods: </bold>In a Danish multicenter trial 319 women were randomized to TAH (n = 158) or SAH (n = 161); 185 women had self-selected TAH (n = 80) or SAH (n = 105) in a simultaneously conducted observational study. Women were followed for 1 year by strict data collection procedures, including postal questionnaires. Results were analyzed by intention to treat (ITT) analyses.<bold>Results: </bold>No significant differences were observed between TAH and SAH at 1-year follow-up in both the randomized trial and the observational study regarding women's desire for sex, frequency of intercourse, frequency of orgasm, quality of orgasm, localization of orgasm, satisfaction with sexual life, and dyspareunia. None of these sexual variables changed significantly from entry to the 1-year follow-up, apart from dyspareunia, which was significantly (p = 0.009) reduced in both intervention groups. Significant (p < 0.05) predictors for satisfaction with sexual life after hysterectomy were the preoperative satisfaction with sexual life [odds ratio (OR) 32, 95% confidence interval (CI) 10-125], good relationship with partner (OR 50, 95% CI 9-354), physical well-being (OR 0.30, 95% CI 0.09-0.88) and hormone replacement therapy (OR 0.23, 95% CI 0.06-0.78).<bold>Conclusions: </bold>Both TAH and SAH significantly reduce dyspareunia without having a negative effect on sexual function. The shift toward SAH seems unwarranted. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00016349
Volume :
83
Issue :
2
Database :
Complementary Index
Journal :
Acta Obstetricia et Gynecologica Scandinavica
Publication Type :
Academic Journal
Accession number :
138156764
Full Text :
https://doi.org/10.1111/j.0001-6349.2004.00311.x